Achieve Life Sciences, Inc. (ACHV)

Last Price:  

Company Description

Achieve Life Sciences Inc. is a pharmaceutical company. It develops and commercializes cytisine treatment to help people battling nicotine addiction. The Company's product candidates include Custirsen, Apatorsen and OGX-225. Achieve Life Sciences Inc., formerly known as OncoGenex Pharmaceuticals Inc., is based in Bothell, United States.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) --
Net Income (Most Recent Fiscal Year) $-16.40M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 1.24
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -94.12%
Return on Assets (Trailing 12 Months) -79.84%
Current Ratio (Most Recent Fiscal Quarter) 6.99
Quick Ratio (Most Recent Fiscal Quarter) 6.99
Debt to Common Equity (Most Recent Fiscal Quarter) 0.01
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $12.24
Earnings per Share (Most Recent Fiscal Quarter) $-1.68
Earnings per Share (Most Recent Fiscal Year) $-39.80
Diluted Earnings per Share (Trailing 12 Months) $-18.88
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 3.59M
Free Float 3.50M
Market Capitalization $33.29M
Average Volume (Last 20 Days) 0.31M
Beta (Past 60 Months) 1.86
Percentage Held By Insiders (Latest Annual Proxy Report) 2.30%
Percentage Held By Institutions (Latest 13F Reports) --
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%